Your boss at La Mega pharmaceutical corporation wishes to add some pizzazz to marketing for a powerful new antibiotic the company developed. She feels that the public won't understand QALYs, so she asks you to present the results of the study in life-years gained. Will this change how you will calculate the cost-effectiveness of the new antibiotic? Solve How? Solve Where do you count costs specific to the time a patient spends ill with the disease?